David Cachia
@davec09.bsky.social
Neuro-oncologist who loves reading and photography in their spare time (what spare time!!!)
Use of ivosidenib in IDHmt Grade2-4 gliomas
Ivosidenib for the treatment of IDH1-mutant glioma, grades 2–4: Tolerability, predictors of response, and outcomes
AbstractBackground. Mutant isocitrate dehydrogenase (IDHm) inhibitors represent a novel targeted approach for treating IDHm glioma patients, yet their opti
academic.oup.com
February 27, 2025 at 1:01 AM
Use of ivosidenib in IDHmt Grade2-4 gliomas
Recently released cIMPACT-NOW update 9
cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics
Abstract. Genome-wide DNA methylation signatures correlate with and distinguish central nervous system (CNS) tumor types. Since the publication of the init
academic.oup.com
February 24, 2025 at 4:54 PM
Recently released cIMPACT-NOW update 9
Important and exciting work by Dr Monje and her team
GABAergic neuron-to-glioma synapses in diffuse midline gliomas - Nature
Functional, tumour-promoting GABAergic neuron-to-glioma synapses in diffuse midline gliomas are identified.
www.nature.com
February 21, 2025 at 11:16 AM
Important and exciting work by Dr Monje and her team